Reach and Engagement of GENetic Education, Risk Assessment, and TEsting Feasibility Trial

This study will test a remote approach to help people who may be at higher risk for pancreatic cancer learn about and decide whether to get genetic testing and a blood test that looks for signs of several cancers (MCED testing). The study is focused on Black, Latino/a, and Medicaid-enrolled individuals who may have had less access to cancer genetics and early detection services. About 80 participants, who reside in Massachusetts, will be assigned by chance to receive either online education alone or online education plus a phone call with a trained educator from the Pancreatic Cancer Action Ne

Trial Details

NCT ID
NCT07787156
Phase
NA
Sponsor
Brigham and Women's Hospital
Status
RECRUITING
Cancer Type
Pancreatic Cancer
Interventions
  • Telephone education session
  • Online educational materials
Locations (sample)
  • Boston, Massachusetts, United States|42.35843,-71.05977

Key Eligibility Criteria

  • Aged 50 years or older OR 10 years younger than the earliest PDAC diagnosis in a family member
  • Current Medicaid enrollment and/or Black and/or Latino/a
  • Willingness to travel to Dana-Farber Cancer Institute in Boston, MA, for diagnostic testing if MCED screening test indicates possible malignancy
  • Living in the state of Massachusetts

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Pancreatic Cancer Trials on Trialify →